Kevin A. D’Amour
Heron Therapeutics (United States)(US)
Publications by Year
Research Areas
Pluripotent Stem Cells Research, Pancreatic function and diabetes, Diabetes Management and Research, Diabetes and associated disorders, Congenital heart defects research
Most-Cited Works
- → Production of pancreatic hormone–expressing endocrine cells from human embryonic stem cells(2006)1,901 cited
- → Pancreatic endoderm derived from human embryonic stem cells generates glucose-responsive insulin-secreting cells in vivo(2008)1,822 cited
- → Efficient differentiation of human embryonic stem cells to definitive endoderm(2005)1,743 cited
- → In Vivo Fate Analysis Reveals the Multipotent and Self-Renewal Capacities of Sox2+ Neural Stem Cells in the Adult Hippocampus(2007)808 cited
- → Activin A Efficiently Specifies Definitive Endoderm from Human Embryonic Stem Cells Only When Phosphatidylinositol 3-Kinase Signaling Is Suppressed(2007)473 cited
- → A Scalable System for Production of Functional Pancreatic Progenitors from Human Embryonic Stem Cells(2012)433 cited
- → Cell-surface markers for the isolation of pancreatic cell types derived from human embryonic stem cells(2011)355 cited
- → Cell fusion-independent differentiation of neural stem cells to the endothelial lineage(2004)355 cited
- → Self-renewal of human embryonic stem cells requires insulin-like growth factor-1 receptor and ERBB2 receptor signaling(2007)314 cited
- → Insulin expression and C-peptide in type 1 diabetes subjects implanted with stem cell-derived pancreatic endoderm cells in an encapsulation device(2021)287 cited